212 related articles for article (PubMed ID: 29330132)
1. An overview of the safety pharmacology society strategic plan.
Pugsley MK; Authier S; Koerner JE; Redfern WS; Markgraf CG; Brabham T; Correll K; Soloviev MV; Botchway A; Engwall M; Traebert M; Valentin JP; Mow TJ; Greiter-Wilke A; Leishman DJ; Vargas HM
J Pharmacol Toxicol Methods; 2018; 93():35-45. PubMed ID: 29330132
[TBL] [Abstract][Full Text] [Related]
2. Methodological innovations expand the safety pharmacology horizon.
Pugsley MK; Curtis MJ
J Pharmacol Toxicol Methods; 2012 Sep; 66(2):59-62. PubMed ID: 22617368
[TBL] [Abstract][Full Text] [Related]
3. Safety pharmacology methods and models in an evolving regulatory environment.
Pugsley MK; de Korte T; Authier S; Huang H; Accardi MV; Curtis MJ
J Pharmacol Toxicol Methods; 2017 Sep; 87():1-6. PubMed ID: 28461240
[TBL] [Abstract][Full Text] [Related]
4. An overview of some pharmacological methods used in safety pharmacology studies.
Pugsley MK
Proc West Pharmacol Soc; 2004; 47():18-22. PubMed ID: 15633602
[TBL] [Abstract][Full Text] [Related]
5. A Historical View and Vision into the Future of the Field of Safety Pharmacology.
Bass AS; Hombo T; Kasai C; Kinter LB; Valentin JP
Handb Exp Pharmacol; 2015; 229():3-45. PubMed ID: 26091634
[TBL] [Abstract][Full Text] [Related]
6. Safety pharmacology: an essential interface of pharmacology and toxicology in the non-clinical assessment of new pharmaceuticals.
Claude JR; Claude N
Toxicol Lett; 2004 Jun; 151(1):25-8. PubMed ID: 15177637
[TBL] [Abstract][Full Text] [Related]
7. The West coast regional safety pharmacology society meeting update: Filling translational gaps in safety assessment.
Abi-Gerges N; McMahon C; Vargas H; Sager P; Chui R; Stevens D; Davila J; Schaub JR; Wu JC; Del Rio C; Mathes C; Miller PE; Burns-Naas LA; Ghetti A
J Pharmacol Toxicol Methods; 2019; 98():106582. PubMed ID: 31077805
[TBL] [Abstract][Full Text] [Related]
8. Recalibration of nonclinical safety pharmacology assessment to anticipate evolving regulatory expectations.
Pugsley MK; Authier S; Hayes ES; Hamlin RL; Accardi MV; Curtis MJ
J Pharmacol Toxicol Methods; 2016; 81():1-8. PubMed ID: 27343819
[TBL] [Abstract][Full Text] [Related]
9. Safety pharmacology methods and regulatory considerations evolve together.
Pugsley MK; Harter ML; de Korte T; Connaughton C; Authier S; Curtis MJ
J Pharmacol Toxicol Methods; 2018; 93():1-6. PubMed ID: 29936032
[No Abstract] [Full Text] [Related]
10. The shifting landscape of safety pharmacology in 2015.
Pugsley MK; Authier S; Stonerook M; Curtis MJ
J Pharmacol Toxicol Methods; 2015; 75():5-9. PubMed ID: 26055120
[TBL] [Abstract][Full Text] [Related]
11. Safety Pharmacology Society: 9th Annual Meeting.
Cavero I
Expert Opin Drug Saf; 2010 Mar; 9(2):365-78. PubMed ID: 20175703
[TBL] [Abstract][Full Text] [Related]
12. Innovation in safety pharmacology testing.
Pugsley MK; Towart R; Authier S; Gallacher DJ; Curtis MJ
J Pharmacol Toxicol Methods; 2011; 64(1):1-6. PubMed ID: 21640842
[TBL] [Abstract][Full Text] [Related]
13. Safety pharmacology in 2010 and beyond: survey of significant events of the past 10 years and a roadmap to the immediate-, intermediate- and long-term future in recognition of the tenth anniversary of the Safety Pharmacology Society.
Bass AS; Vargas HM; Valentin JP; Kinter LB; Hammond T; Wallis R; Siegl PK; Yamamoto K
J Pharmacol Toxicol Methods; 2011; 64(1):7-15. PubMed ID: 21689769
[TBL] [Abstract][Full Text] [Related]
14. Safety pharmacology in focus: new methods developed in the light of the ICH S7B guidance document.
Pugsley MK; Curtis MJ
J Pharmacol Toxicol Methods; 2006; 54(2):94-8. PubMed ID: 16806993
[TBL] [Abstract][Full Text] [Related]
15. The Diplomate in Safety Pharmacology (DSP) certification scheme.
Authier S; Curtis MJ; Soloviev M; Redfern WS; Kallman MJ; Hamlin RL; Leishman DJ; Valentin JP; Koerner JE; Vargas HM; Botchway A; Correll K; Pugsley MK
J Pharmacol Toxicol Methods; 2015; 75():1-4. PubMed ID: 25959882
[TBL] [Abstract][Full Text] [Related]
16. Safety Pharmacology Society: 7th annual meeting 19 - 20 September 2007, Edinburgh, UK.
Cavero I
Expert Opin Drug Saf; 2008 Jan; 7(1):91-100. PubMed ID: 18171317
[No Abstract] [Full Text] [Related]
17. Trends in safety pharmacology: posters presented at the annual meetings of the Safety Pharmacology Society 2001-2010.
Redfern WS; Valentin JP
J Pharmacol Toxicol Methods; 2011; 64(1):102-10. PubMed ID: 21635957
[TBL] [Abstract][Full Text] [Related]
18. Beyond the safety assessment of drug-mediated changes in the QT interval... what's next?
Pugsley MK; Authier S; Towart R; Gallacher DJ; Curtis MJ
J Pharmacol Toxicol Methods; 2009; 60(1):24-7. PubMed ID: 19616107
[TBL] [Abstract][Full Text] [Related]
19. Response of safety pharmacologists to challenges arising from the rapidly evolving changes in the pharmaceutical industry.
Bass AS; Pugsley MK; Sannajust F; Yoshinaga T; Valentin JP
J Pharmacol Toxicol Methods; 2019; 98():106593. PubMed ID: 31158459
[TBL] [Abstract][Full Text] [Related]
20. Methods in safety pharmacology in focus.
Pugsley MK; Gallacher DJ; Towart R; Authier S; Curtis MJ
J Pharmacol Toxicol Methods; 2008; 58(2):69-71. PubMed ID: 18707009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
